UNSPSC 85815521: Introduction of clofarabine into central artery, percutaneous approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of clofarabine into central artery, percutaneous approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0630P

UNSPSC 85815521 Introduction of clofarabine into central artery, percutaneous approach is a Commodity code with minimal recent activity in state and local procurement markets. The code describes a specific medical procedure—intra-arterial administration of clofarabine, a chemotherapy agent—yet the recent opportunities posted under this taxonomy do not align with procedural services or oncology care delivery. Instead, the opportunities span telehealth urgent care, general medical services contracting, and complex behavioral health operations across multiple states and jurisdictions, indicating either misclassification in the source data or marginal relevance of this code to active state and local buying patterns.

The issuing bodies posting opportunities near this code's taxonomy include large health plans (Inland Empire Health Plan, California), county health authorities (DeKalb County, Georgia; Nevada Health Authority), municipal and regional health systems (San Mateo County Medical Center, Santa Clara County Health System), and specialized agencies (Colorado Department of Human Services, Seminole County Emergency Medical Services). The geographic spread encompasses California, Nevada, Georgia, Colorado, Arizona, Florida, and Texas. Representative recent opportunities include the Nevada Health Authority's RFP 41NHA-S4038 for Program of All Inclusive Care for the Elderly (PACE) operations due December 10, 2026, covering comprehensive elderly services across Nevada service areas at fixed monthly capitation rates; San Mateo County's RFP for Cancer Registry Services due November 6, 2026, seeking oncology data management; and the City of Phoenix's five-year cancer screening services RFP with a maximum annual value of $3.5 million due February 2, 2026. The code shows little procurement traction for the specific intra-arterial clofarabine procedure itself; activity clusters instead around occupational health, telehealth, behavioral health integration, emergency services, and chronic disease management infrastructure contracts where state and local governments are active buyers right now.